Travel Interventional Radiologist — Flexible Schedule, Top Pay

Odyssey Locums; Bismarck (ND); Sur place; USD 165 000 - 248 000; Plein temps

Avantages offerts par ce poste

Premium hourly pay

Paid housing and travel

Tail malpractice insurance with tail

24/7 recruiter support

Referral bonus program

Résumé du poste

Odyssey Locums is seeking an Interventional Radiology locum in Bismarck, ND, with 60–90 day credentialing and on-site coverage. The assignment spans 2026/2027, with a 8:00 AM–4:00 PM day shift and on-call responsibilities.

Travel and housing are provided, and the IR residency or fellowship plus board certification are required. Qualified candidates must hold an ND license (or IMLC) and have ACLS/BLS; experience in angiography, angioplasty, and thrombolytic therapies is expected.

Qualifications

• BC in IR (Board Certified in Interventional Radiology) is required or equivalent.
• Active ND License or IMLC; willingness to obtain state license.
• ACLS and BLS certifications are required.
• IR residency or fellowship and Board Certification in IR are required.

Responsabilités

• Perform diagnostic vascular interventions including angiography.
• Perform therapeutic vascular interventions (angioplasty, stenting).
• Manage vascular access devices (PICC, central lines, ports).
• Provide stroke care capability and IR coverage as needed.
• Coordinate with credentialing and scheduling for timely assignments.

Connaissances

IR board certification

Interventional radiology

ACLS

BLS

Formation

IR residency or fellowship

Board certification in IR

Outils

Epic EMR

Description du poste

Odyssey Locums is seeking an Interventional Radiology locum in Bismarck, ND, with 60–90 day credentialing and on-site coverage. The assignment spans 2026/2027, with a 8:00 AM–4:00 PM day shift and on-call responsibilities.

Travel and housing are provided, and the IR residency or fellowship plus board certification are required. Qualified candidates must hold an ND license (or IMLC) and have ACLS/BLS; experience in angiography, angioplasty, and thrombolytic therapies is expected.